Clinical aspects of SDHx-related pheochromocytoma and paraganglioma

Endocrine-Related Cancer

Volumn 16, Issue 2, 2009, Pages 391-400

  Timmers, Henri J L M ^a   Gimenez Roqueplo, Anne Paule ^b,c,d   Mannelli, Massimo ^e   Pacak, Karel ^f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e UNIVERSITY OF FLORENCE   (Italy)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 125; 6 FLUORODOPAMINE F 18; ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; FLUORODEOXYGLUCOSE F 18; HYPOXIA INDUCIBLE FACTOR 1ALPHA; METIROSINE; NORADRENALIN; PROPRANOLOL; SUCCINATE DEHYDROGENASE; VINCRISTINE;

ADRENALIN BLOOD LEVEL; APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ENZYME ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE LOSS; GENE MUTATION; GENE NUMBER; GENE TARGETING; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LAPAROTOMY; NORADRENALIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PROGNOSIS; REVIEW; SURVIVAL RATE; TREATMENT RESPONSE; UPREGULATION; ADRENAL TUMOR; GENETICS; MUTATION;

ADRENAL GLAND NEOPLASMS; HUMANS; MUTATION; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE;

EID: 67650501167     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0284     Document Type: Review

References (74)

1. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A et al. 2005 a Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology 23 8812-8818.
2. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G & Plouin PF 2005b Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. Journal of Clinical Endocrinology and Metabolism 90 2110-2116.
3. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP et al. 2007 Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 3822-3828.
4. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE & Baysal BE 2003 Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Human Genetics 113 228-237.
5. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C & Maher ER 2001 Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics 69 49-54.
6. Averbuch SD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R & Keiser HR 1988 Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Annals of Internal Medicine 109 267-273.
7. Bauters C, Vantyghem MC, Leteurtre E, Odou MF, Mouton C, Porchet N, Wemeau JL, Proye C, Wemeau JL, Proye C et al. 2003 Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes. Journal of Medical Genetics 40 e75.
8. Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC et al. 2006 Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Medical Genetics 7 1.
9. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN et al. 2000 Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287 848-851.
10. Baysal BE, Willett-Brozick JE, Filho PA, Lawrence EC, Myers EN & Ferrell RE 2004 An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. Journal of Medical Genetics 41 703-709.
11. Benn DE & Robinson BG 2006 Genetic basis of phaeochromocytoma and paraganglioma. Best Practice and Research. Clinical Endocrinology and Metabolism 20 435-450.
12. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O et al. 2006 Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. Journal of Clinical Endocrinology and Metabolism 91 827-836.
13. Birch-Machin MA, Taylor RW, Cochran B, Ackrell BA & Turnbull DM 2000 Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Annals of Neurology 48 330-335.
14. Bonnet S, Durand X, Baton O, Gimenez-Roqueplo AP, Baudin E, Visset J, Algayres JP & Baranger B 2006 Malignant hereditary paraganglioma: problems raised by non-functional forms management. Annales de Chirurgie 131 626-630.
15. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A & Rotig A 1995 Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genetics 11 144-149.
16. Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM & Pacak K 2006 High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. Journal of Clinical Endocrinology and Metabolism 91 4505-4509.
17. Cascon A, Montero-Conde C, Ruiz-Llorente S, Mercadillo F, Leton R, Rodriguez-Antona C, Martinez-Delgado B, Delgado M, Diez A, Rovira A et al. 2006 Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot? Genes, Chromosomes and Cancer 45 213-219.
18. Dahia PL, Hao K, Rogus J, Colin C, Pujana MA, Ross K, Magoffin D, Aronin N, Cascon A, Hayashida CY et al. 2005 Novel pheochromocytoma susceptibility loci identified by integrative genomics. Cancer Research 65 9651-9658.
19. DeLellis RA, Lloyd RV, Heitz PU & Eng C 2004 Pathology and Genetics: World Health Organization Classification of Tumours of Endocrine Organs. Oxford, UK: Oxford University Press.
20. Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, Giordano TJ, Greene LA, Goldstein DS, Lehnert H et al. 2004 Malignant pheochromocytoma: current status and initiatives for future progress. Endocrine-Related Cancer 11 423-436.
21. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT & Pacak K 2005a Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. Journal of Clinical Endocrinology and Metabolism 90 2068-2075.
22. Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM, Brouwers FM & Pacak K 2005b Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clinical Chemistry 51 735-744.
23. Elston MS, Benn D, Robinson BG & Conaglen JV 2006 An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years. Internal Medicine Journal 36 129-131.
24. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA & Young WF Jr 2001 Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. Journal of Clinical Endocrinology and Metabolism 86 5210-5216.
25. Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L et al. 2006 Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Annals of the New York Academy of Sciences 1073 465-490.
26. Fokkema IF, den Dunnen JT & Taschner PE 2005 LOVD: easy creation of a locus-specific sequence variation database using an 'LSDB-in-a-box' approach. Human Mutation 26 63-68.
27. Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, Rotig A & Jeunemaitre X 2001 The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. American Journal of Human Genetics 69 1186-1197.
28. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Kerlan V, Plouin PF, Rotig A & Jeunemaitre X 2002 Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 87 4771-4774.
29. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF & Jeunemaitre X 2003 Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Research 63 5615-5621.
30. Gimenez-Roqueplo AP, Lehnert H, Mannelli M, Neumann H, Opocher G, Maher ER & Plouin PF 2006 Phaeochromocytoma, new genes and screening strategies. Clinical Endocrinology 65 699-705.
31. Gimm O, Armanios M, Dziema H, Neumann HP & Eng C 2000 Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Research 60 6822-6825.
32. Goldstein RE, O'Neill JA Jr, Holcomb GW III, Morgan WM III, Neblett WW III, Oates JA, Brown N, Nadeau J, Smith B, Page DL et al. 1999 Clinical experience over 48 years with pheochromocytoma. Annals of Surgery 229 755-764.
33. Gottlieb E & Tomlinson IP 2005 Mitochondrial tumour suppressors: a genetic and biochemical update. Nature Reviews. Cancer 5 857-866.
34. Havekes B, Corssmit EP, Jansen JC, van der Mey AG, Vriends AH & Romijn JA 2007 Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. Journal of Clinical Endocrinology and Metabolism 92 1245-1248.
35. Hull MT, Roth LM, Glover JL & Walker PD 1982 Metastatic carotid body paraganglioma in von Hippel-Lindau disease. An electron microscopic study. Archives of Pathology & Laboratory Medicine 106 235-239.
36. Ilias I, Shulkin B & Pacak K 2005 New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Trends in Endocrinology and Metabolism 16 66-72.
37. Janetschek G, Finkenstedt G, Gasser R, Waibel UG, Peschel R, Bartsch G & Neumann HP 1998 Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. Journal of Urology 160 330-334.
38. John H, Ziegler WH, Hauri D & Jaeger P 1999 Pheochromocytomas: can malignant potential be predicted? Urology 53 679-683.
39. Khorram-Manesh A, Ahlman H, Nilsson O, Friberg P, Oden A, Stenstrom G, Hansson G, Stenquist O, Wangberg B, Tisell LE et al. 2005 Long-term outcome of a large series of patients surgically treated for pheochromocytoma. Journal of Internal Medicine 258 55-66.
40. Kwekkeboom DJ, van Urk H, Pauw BK, Lamberts SW, Kooij PP, Hoogma RP & Krenning EP 1993 Octreotide scintigraphy for the detection of paragangliomas. Journal of Nuclear Medicine 34 873-878.
41. Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin WG Jr et al. 2005 Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8 155-167.
42. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS & Eisenhofer G 2002 Biochemical diagnosis of pheochromocytoma: which test is best? Journal of the American Medical Association 287 1427-1434.
43. Lenders JW, Eisenhofer G, Mannelli M & Pacak K 2005 Phaeochromocytoma. Lancet 366 665-675.
44. Linnoila RI, Keiser HR, Steinberg SM & Lack EE 1990 Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Human Pathology 21 1168-1180.
45. Mannelli M, Ercolino T, Giache V, Simi L, Cirami C & Parenti G 2007 Genetic screening for pheochromocytoma: should SDHC gene analysis be included? Journal of Medical Genetics 44 586-587.
46. Maurea S, Cuocolo A, Reynolds JC, Neumann RD & Salvatore M 1996 Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Quarterly Journal of Nuclear Medicine 40 365-371.
47. McWhinney SR, Pilarski RT, Forrester SR, Schneider MC, Sarquis MM, Dias EP & Eng C 2004 Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. Journal of Clinical Endocrinology and Metabolism 89 5694-5699.
48. Mundschenk J & Lehnert H 1998 Malignant pheochromocytoma. Experimental and Clinical Endocrinology and Diabetes 106 373-376.
49. van Nederveen FH, Korpershoek E, Lenders JW, de Krijger RR & Dinjens WN 2007 Somatic SDHB mutation in an extraadrenal pheochromocytoma. New England Journal of Medicine 357 306-308.
50. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K et al. 2002 Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 346 1459-1466.
51. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA et al. 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Journal of the American Medical Association 292 943-951.
52. Niemann S & Muller U 2000 Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genetics 26 268-270.
53. Niemann U, Hiller W & Behrend M 2002 25 years experience of the surgical treatment of phaeochromocytoma. European Journal of Surgery 168 716-719.
54. Niemann S, Muller U, Engelhardt D & Lohse P 2003 Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC. Human Genetics 113 92-94.
55. Ogawa K, Shiga K, Saijo S, Ogawa T, Kimura N & Horii A 2006 A novel G106D alteration of the SDHD gene in a pedigree with familial paraganglioma. American Journal of Medical Genetics. Part A 140 2441-2446.
56. Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST & Goldstein DS 2001 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38 6-8.
57. Pacak K, Keiser H & Eisenhofer G 2005 Pheochromocytoma. In Textbook of Endocrinology, edn 5, pp 2501-2534. Philadelphia, PA: Elsevier Saunders, Inc.
58. Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA, Ferrando B, Pacak K, Assie G et al. 2008 Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. European Journal of Human Genetics 16 79-88.
59. Peczkowska M, Cascon A, Prejbisz A, Kubaszek A, Cwikla BJ, Furmanek M, Erlic Z, Eng C, Januszewicz A & Neumann HP 2008 Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Nature Clinical Practice. Endocrinology & Metabolism 4 111-115.
60. Pham TH, Moir C, Thompson GB, Zarroug AE, Hamner CE, Farley D, van Heerden J, Lteif AN & Young WF Jr 2006 Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics 118 1109-1117.
61. Plouin PF, Chatellier G, Fofol I & Corvol P 1997 Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension 29 1133-1139.
62. Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, Latif F & Maher ER 2008 Germline SDHB mutations and familial renal cell carcinoma. Journal of the National Cancer Institute 100 1260-1262.
63. Scheffler IE 1998 Molecular genetics of succinate:quinone oxidoreductase in eukaryotes. Progress in Nucleic Acid Research and Molecular Biology 60 267-315.
64. Schiavi F, Boedeker CC, Bausch B, Peczkowska M, Gomez CF, Strassburg T, Pawlu C, Buchta M, Salzmann M, Hoffmann MM et al. 2005 Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. Journal of the American Medical Association 294 2057-2063.
65. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB & Gottlieb E 2005 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 77-85.
66. Stenstrom G, Ernest I & Tisell LE 1988 Long-term results in 64 patients operated upon for pheochromocytoma. Acta Medica Scandinavica 223 345-352.
67. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW & Pacak K 2007a Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with SDHB-associated pheochromocytomas and paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 779-786.
68. Timmers HJ, Kozupa K, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW & Pacak K 2007b Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. Journal of Clinical Oncology 26 2262-2269.
69. Timmers HJ, Pacak K, Bertherat J, Lenders JW, Duet M, Eisenhofer G, Stratakis CA, Niccoli-Sire P, Tran BH, Burnichon N et al. 2008a Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clinical Endocrinology 68 561-566.
70. Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ, Baysal BE, Adams KT & Eisenhofer G 2008b Biochemically silent abdominal paragangliomas in patients with mutations in the Sdhb gene. Journal of Clinical Endocrinology and Metabolism 93 4826-4832.
71. Vanharanta S, Buchta M, McWhinney SR, Virta SK, Peczkowska M, Morrison CD, Lehtonen R, Januszewicz A, Jarvinen H, Juhola M et al. 2004 Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. American Journal of Human Genetics 74 153-159.
72. Warburg O 1956 On the origin of cancer cells. Science 123 309-314.
73. Young WF Jr & Abboud AL 2006 Editorial: paragangliomaall in the family. Journal of Clinical Endocrinology and Metabolism 91 790-792.
74. Young AL, Baysal BE, Deb A & Young WF Jr 2002 Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. Journal of Clinical Endocrinology and Metabolism 87 4101-4105.